search
Back to results

Effect of Platelet Rich Plasma on Healing of Operated Pilonidal Sinus by Open Method

Primary Purpose

Pilonidal Disease of Natal Cleft

Status
Completed
Phase
Not Applicable
Locations
Egypt
Study Type
Interventional
Intervention
Platelet Rich Plasma
Sponsored by
Kafrelsheikh University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Pilonidal Disease of Natal Cleft

Eligibility Criteria

18 Years - 45 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Patient age >18 years and <45 years.
  2. All patient who underwent sacrococcygeal pilonidal sinus operation (Open method).

Exclusion Criteria:

  1. Pilonidal abscess.
  2. Diabetic patient.
  3. HGB < 10 g/dl.
  4. Platelet count < 105/ul.
  5. Anticoagulant treatment.
  6. Wound cavity >35cc.

Sites / Locations

  • Kafr El Sheikh University Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Active Comparator

Arm Label

Group A

Group B

Arm Description

50 Participants who underwent a total excision of the pilonidal sinus and the wound remained open for secondary healing.

50 Participants who underwent the same operation with secondary healing intention but on postoperative days 4 and 12 the platelet rich plasma was injected to the surgical wound.

Outcomes

Primary Outcome Measures

Assessment of the wound capacity
Evaluation of Wound volume on postoperative days till complete healing of the wound in each group and compare rate of healing in both groups.

Secondary Outcome Measures

Full Information

First Posted
June 10, 2020
Last Updated
June 11, 2020
Sponsor
Kafrelsheikh University
search

1. Study Identification

Unique Protocol Identification Number
NCT04430413
Brief Title
Effect of Platelet Rich Plasma on Healing of Operated Pilonidal Sinus by Open Method
Official Title
Assessment of the Effect of Platelet Rich Plasma on the Healing of Operated Sacrococcygeal Pilonidal Sinus by Open Method
Study Type
Interventional

2. Study Status

Record Verification Date
June 2020
Overall Recruitment Status
Completed
Study Start Date
December 1, 2018 (Actual)
Primary Completion Date
December 1, 2019 (Actual)
Study Completion Date
December 31, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Kafrelsheikh University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
The aim of the study is to assess the healing promotion effect of platelet rich plasma in patient being operated for sacrococcygeal pilonidal sinus disease by open excision
Detailed Description
Sacrococcygeal Pilonidal disease is an infection of the skin and subcutaneous tissue at or near the upper part of the natal cleft of the buttocks. Pilonidal cavities are not true cysts and lack a fully epithelialized lining; however, the sinus tracts may be epithelialized. Pilonidal sinus disease (PNS) has an incidence of approximately 26 per 100,000 population with a male predominance of 2:1 and the mean age of those affected is from 19 to 30 years of age. It occurs rarely after the age of 45 and children. Pilonidal sinus disease is characterized by natal cleft suppuration due to hair follicle infection. The disease results from chronic infection of hair follicles and subsequent formation of a subcutaneous abscess because of persistent folliculitis. Hair then enters the abscess cavity and provokes a foreign body tissue reaction; chronic suppuration and discharge through a midline sinus follow. Some individuals are asymptomatic with midline pits in the sacrococcygeal area, Symptomatic Pilonidal sinus results in chronic discharging wounds that cause pain and impact upon quality of life and social function. These sinuses may become infected and present as acute abscesses. Management of these abscesses is uncontroversial and revolves around incision and drainage, however, the mode of surgical management of the chronic discharging sinus is variable, contentious, and problematic. The Principles of Surgical strategies require eradication of the sinus tract, complete healing of the overlying skin, and prevention of recurrence. Many methods are available for surgical management of PNS which is treated by wide excision. After excision, the wound may be left open to heal with granulation tissue, or may be immediate closed with a midline closure or by using a flap (Z-plasty, karydakis, Bascom or Rhomboid flaps). However, there is not yet a consensus on the optimal treatment. Excision and healing by granulation is still preferred due to the low recurrence rate of (3.4%) compering with other methods (20.6%) for midline closure and (10.3%) for off-midline closure but the healing time is lengthy and requires a prolonged time of daily dressing with a risk of infection and delayed wound healing. Therefore, the search for a treatment with minimal pain, accelerated healing time and a short span of time for returning to the normal daily activities is vastly pursued. A recent method to promote the wound-healing process is the local administration of an autologous platelet concentrate suspended in plasma named as platelet rich plasma (PRP) which contains growth factors. Concentrated growth factors have been reported to accelerate wound healing by 30-40% giving a satisfactory outcome in the treatment of chronic skin and soft tissue lesions, maxillofacial and plastic surgeries by presenting these high amounts of growth factors and chemokines. When platelets become activated, Seven fundamental protein growth factors that are actively secreted by platelet initiate all wound healing process, including platelet derived growth factor (PDGF), epidermal growth factor (EGF), transforming growth factor (TGF), vascular endothelial growth factor (VEGF), Fibroblast growth factor (FGF), connective tissue growth factor (CTGF) & insulin like growth factor (ILGF 1) all participate in the acceleration of wound-healing process.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pilonidal Disease of Natal Cleft

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
100 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Group A
Arm Type
No Intervention
Arm Description
50 Participants who underwent a total excision of the pilonidal sinus and the wound remained open for secondary healing.
Arm Title
Group B
Arm Type
Active Comparator
Arm Description
50 Participants who underwent the same operation with secondary healing intention but on postoperative days 4 and 12 the platelet rich plasma was injected to the surgical wound.
Intervention Type
Biological
Intervention Name(s)
Platelet Rich Plasma
Intervention Description
Autologous PRP obtained via double centrifugation process of the participant's blood sample. PRP was prepared by the double Spain strategy.
Primary Outcome Measure Information:
Title
Assessment of the wound capacity
Description
Evaluation of Wound volume on postoperative days till complete healing of the wound in each group and compare rate of healing in both groups.
Time Frame
One Year

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
45 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patient age >18 years and <45 years. All patient who underwent sacrococcygeal pilonidal sinus operation (Open method). Exclusion Criteria: Pilonidal abscess. Diabetic patient. HGB < 10 g/dl. Platelet count < 105/ul. Anticoagulant treatment. Wound cavity >35cc.
Facility Information:
Facility Name
Kafr El Sheikh University Hospital
City
Kafr Ash Shaykh
State/Province
Kafr El Sheikh Governorate
ZIP/Postal Code
33511
Country
Egypt

12. IPD Sharing Statement

Citations:
PubMed Identifier
19010110
Citation
Acarturk TO, Parsak CK, Sakman G, Demircan O. Superior gluteal artery perforator flap in the reconstruction of pilonidal sinus. J Plast Reconstr Aesthet Surg. 2010 Jan;63(1):133-9. doi: 10.1016/j.bjps.2008.07.017. Epub 2008 Nov 14.
Results Reference
background
PubMed Identifier
11266254
Citation
Al-Jaberi TM. Excision and simple primary closure of chronic pilonidal sinus. Eur J Surg. 2001 Feb;167(2):133-5. doi: 10.1080/110241501750070600.
Results Reference
background
PubMed Identifier
17943897
Citation
McCallum I, King PM, Bruce J. Healing by primary versus secondary intention after surgical treatment for pilonidal sinus. Cochrane Database Syst Rev. 2007 Oct 17;(4):CD006213. doi: 10.1002/14651858.CD006213.pub2.
Results Reference
background
PubMed Identifier
18193323
Citation
Anderson JH, Yip CO, Nagabhushan JS, Connelly SJ. Day-case Karydakis flap for pilonidal sinus. Dis Colon Rectum. 2008 Jan;51(1):134-8. doi: 10.1007/s10350-007-9150-y. Epub 2008 Jan 12.
Results Reference
background
PubMed Identifier
22399039
Citation
Aksahin E, Dogruyol D, Yuksel HY, Hapa O, Dogan O, Celebi L, Bicimoglu A. The comparison of the effect of corticosteroids and platelet-rich plasma (PRP) for the treatment of plantar fasciitis. Arch Orthop Trauma Surg. 2012 Jun;132(6):781-5. doi: 10.1007/s00402-012-1488-5. Epub 2012 Mar 8.
Results Reference
background
PubMed Identifier
32962673
Citation
Gohar MM, Ali RF, Ismail KA, Ismail TA, Nosair NA. Assessment of the effect of platelet rich plasma on the healing of operated sacrococcygeal pilonidal sinus by lay-open technique: a randomized clinical trial. BMC Surg. 2020 Sep 22;20(1):212. doi: 10.1186/s12893-020-00865-x.
Results Reference
derived

Learn more about this trial

Effect of Platelet Rich Plasma on Healing of Operated Pilonidal Sinus by Open Method

We'll reach out to this number within 24 hrs